https://www.selleckchem.com/pr....oducts/rhosin-hydroc
esults. (Clinical trial registration number NTC03126513.). G-POEM is an effective 4-year treatment in patients with RG, especially in DG, establishing a potential first-line therapy in these patients. However, randomized controlled clinical trials are needed to confirm these results. (Clinical trial registration number NTC03126513.). Studies have probed the function of microRNA (miR)-16-5p in the progression of atherosclerosis (AS), while the regulatory function of exosomal miR-16-5p from macrophage on AS remains largely un
Like
Comment
Share
